ALISO VIEJO, Calif., July 23, 2025 /PRNewswire/ -- In a major milestone for chronic post-amputation pain treatment, the first commercial patient in the U.S. has been successfully implanted with the ...
Guidelines support increasing treatment access for patients given the clinical evidence in addressing chronic pain -CLEVELAND ...
The U.S. Food and Drug Administration is taking North Chicago-based drugmaker AbbVie to task, warning in a recent letter that a migraine medication commercial featuring Serena Williams is “misleading.
Vertex has begun a full-court press for Journavx, enlisting NBA All-Star Jayson Tatum to discuss his use of the new non-opioid painkiller while recovering from a serious injury. Tatum ruptured his ...
TONMYA is now available by prescription and available for pharmacy ordering nationwideTONMYA is the first FDA-approved treatment for fibromyalgia ...
Pain Management & Rehab Center in Springfield, Massachusetts, has expanded its specialized muscle therapy services to meet increasing patient demand for comprehensive, non-invasive pain treatment ...
Tonix said Monday before the bell that its non-opioid, once-daily treatment, Tonmya, is the first FDA-approved fibromyalgia therapy in more than 15 years. The drug delivered significant reductions in ...
Eli Lilly is expanding its pain drug pipeline with the acquisition of SiteOne Therapeutics, a startup with a lead program that addresses the same target as a Vertex Pharmaceuticals product whose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback